Amit Hasija Net Worth

Mr. Amit Hasija biography

Amit Hasija is the CFO & Exec. VP of Corp. Devel. at Milestone Pharmaceuticals Inc.

What is the salary of Mr Hasija?

As the CFO & Exec. VP of Corp. Devel. of Milestone Pharmaceuticals Inc, the total compensation of Mr Hasija at Milestone Pharmaceuticals Inc is $442,224. There are 1 executives at Milestone Pharmaceuticals Inc getting paid more, with Joseph G. Oliveto having the highest compensation of $646,383.

How old is Mr Hasija?

Mr Hasija is 48, he's been the CFO & Exec. VP of Corp. Devel. of Milestone Pharmaceuticals Inc since . There are 5 older and no younger executives at Milestone Pharmaceuticals Inc. The oldest executive at Milestone Pharmaceuticals Inc is Dr. Philip T. Sager FACC, FAHA, FHRS, M.D., 65, who is the Chief Medical Advisor & Member of the Scientific Advisory Board.

What's Mr Hasija's mailing address?

Amit's mailing address filed with the SEC is C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, A8, H4M 2X6.

Insiders trading at Milestone Pharmaceuticals Inc

Over the last 6 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic..., and Joseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.

What does Milestone Pharmaceuticals Inc do?

milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.

Milestone Pharmaceuticals Inc executives and stock owners

Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Joseph G. Oliveto,
  CEO, Pres & Director
• Amit Hasija,
  CFO & Exec. VP of Corp. Devel.
• Dr. Francis Plat,
  Chief Medical Officer
• Lorenz Muller,
  Chief Commercial Officer
• Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.,
  Chief Medical Advisor & Member of the Scientific Advisory Board
• Jeff Nelson,
  Chief Operating Officer
• Dr. Philippe Douville,
  Founder, Strategic Advisor & Member of Scientific Advisory Board
• Richard C Pasternak,
  Director
• Debra K. Liebert,
  Director
• Paul F Truex,
  Director
• Joseph C Papa,
  
• Amit Hasija,
  CFO & EVP of Corp. Development
• Seth H. Z. Fischer,
  
• Timothy Maness,
  Chief Accounting Officer
• Philippe Douville,
  Chief Scientific Officer
• De Solidarite Des Travaille...,
  10% owner
• Holdings A/S Novo,
  10% owner
• Investments, Lpwong Roderic...,
  
• Capital Inc. Bdc,
  10% owner
• Francis Plat,
  Chief Medical Officer
• Joseph Oliveto,
  President and CEO
• Lorenz Muller,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Michael John Tomsicek,
  
• Stuart Duty,
  
• David Bharucha,
  Chief Medical Officer
• Jeffrey Edward Nelson,
  Chief Operating Officer
• Lisa M. Giles,
  
• Robert James Wills,